Cytoplasmic abnormalities of erythroblasts as a marker for ringed sideroblasts in myelodysplastic syndromes

Is there a pressing need for improving prognostication strategies in therapy-related myelodysplastic syndromes?

Leukemia·2017

PARP-2 sustains erythropoiesis in mice by limiting replicative stress in erythroid progenitors.

Cell death and differentiation·2014

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q.

Leukemia·2010

Immunophenotype of acute myeloid leukemia with NPM mutations: prognostic impact of the leukemic compartment size.

Leukemia research·2010

Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status.

International journal of hematology·2008

Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia.

Leukemia·2008

BCMA-Targeted Immunotherapy in Early Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Practical Management.

European journal of haematology·2026

Beyond Extranodal Site Count: Clinical and Anatomical Characterization of Primary Multifocal Extranodal Diffuse Large B-Cell Lymphoma.

European journal of haematology·2026

Patient and Healthcare Provider Satisfaction With Subcutaneous Versus Intravenous Administration of Daratumumab in Combination With Lenalidomide and Dexamethasone as First-Line Treatment in Patients With Newly Diagnosed Non-Transplant Eligible Multiple Myeloma: Final Results of the MYLENE Study.

European journal of haematology·2026

BCMA Targeted Therapies and Their Impact on Outcomes in Relapsed or Refractory Multiple Myeloma: Results From the French EMMY Cohort.

European journal of haematology·2026

Castleman Disease: Unraveling Diagnostic Challenges Through Clinical and Pathologic Perspectives.

European journal of haematology·2026

Posaconazole Prophylaxis for the Prevention of Invasive Fungal Infections in Patients With Hematologic Malignancies: A Systematic Review and Meta-Analysis.

European journal of haematology·2026

Time-Dependent Prognostic Value of the sCD25-to-Ferritin Ratio in Chronic Active Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.

Infectious diseases and therapy·2026

Haemophagocytic Lymphohistiocytosis Triggered by Visceral Leishmaniasis Masquerading as Epstein-Barr Virus (EBV)-Associated Haemophagocytic Lymphohistiocytosis in Rheumatoid Arthritis: A Case Report and Literature Review.

Cureus·2026

A rare case of dysplasia epiphysealis hemimelica in a hip joint treated by arthroscopic tumour resection: a case report.

Journal of hip preservation surgery·2026

Probing Red Blood Cell Deformability in Sickle Cell Disease, Sickle Cell Trait, and Healthy Controls by Ektacytometry.

EJHaem·2026

Adjunctive Intravenous Iron and Early Hematologic Recovery after Gynecologic Surgery.

Maedica·2026

Recent trends and innovative strategies in the curative approach for β-thalassemia: a current prospect and future perspective.

Molecular biology reports·2026

Related Experiment Videos

Cytoplasmic abnormalities of erythroblasts as a marker for ringed sideroblasts in myelodysplastic syndromes

Related Concept Videos

Is there a pressing need for improving prognostication strategies in therapy-related myelodysplastic syndromes?

PARP-2 sustains erythropoiesis in mice by limiting replicative stress in erythroid progenitors.

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q.

Immunophenotype of acute myeloid leukemia with NPM mutations: prognostic impact of the leukemic compartment size.

Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status.

Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia.

BCMA-Targeted Immunotherapy in Early Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Practical Management.

Beyond Extranodal Site Count: Clinical and Anatomical Characterization of Primary Multifocal Extranodal Diffuse Large B-Cell Lymphoma.

Patient and Healthcare Provider Satisfaction With Subcutaneous Versus Intravenous Administration of Daratumumab in Combination With Lenalidomide and Dexamethasone as First-Line Treatment in Patients With Newly Diagnosed Non-Transplant Eligible Multiple Myeloma: Final Results of the MYLENE Study.

BCMA Targeted Therapies and Their Impact on Outcomes in Relapsed or Refractory Multiple Myeloma: Results From the French EMMY Cohort.

Castleman Disease: Unraveling Diagnostic Challenges Through Clinical and Pathologic Perspectives.

Posaconazole Prophylaxis for the Prevention of Invasive Fungal Infections in Patients With Hematologic Malignancies: A Systematic Review and Meta-Analysis.

Time-Dependent Prognostic Value of the sCD25-to-Ferritin Ratio in Chronic Active Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.

Haemophagocytic Lymphohistiocytosis Triggered by Visceral Leishmaniasis Masquerading as Epstein-Barr Virus (EBV)-Associated Haemophagocytic Lymphohistiocytosis in Rheumatoid Arthritis: A Case Report and Literature Review.

A rare case of dysplasia epiphysealis hemimelica in a hip joint treated by arthroscopic tumour resection: a case report.

Probing Red Blood Cell Deformability in Sickle Cell Disease, Sickle Cell Trait, and Healthy Controls by Ektacytometry.

Adjunctive Intravenous Iron and Early Hematologic Recovery after Gynecologic Surgery.

Recent trends and innovative strategies in the curative approach for β-thalassemia: a current prospect and future perspective.

Related Experiment Videos

Cytoplasmic abnormalities of erythroblasts as a marker for ringed sideroblasts in myelodysplastic syndromes

Related Concept Videos

Related Articles